[1] Gurdon JB, Byrne JA. The first half-century of nuclear transplantation. Proc Natl Acad Sci USA, 2003, 100(14): 8048–8052.
[2] Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature, 1997, 385(6619): 810–813.
[3] Yamanaka S. Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B Biol Sci, 2008, 363(1500): 2079–2087.
[4] Han YM, Kang YK, Koo DB, Lee KK. Nuclear repro-gramming of cloned embryos produced in vitro. Therio-genology, 2003, 59(1): 33–44.
[5] Cibelli JB, Campbell KH, Seidel GE, West MD, Lanza RP. The health profile of cloned animals. Nat Biotechnol, 2002, 20(1): 13–14.
[6] Delcuve GP, Rastegar M, Davie JR. Epigenetic control. J Cell Physiol, 2009, 219(2): 243–250.
[7] Bird A. DNA methylation patterns and epigenetic memory. Genes Dev, 2002, 16(1): 6–21.
[8] Shi W, Zakhartchenko V, Wolf E. Epigenetic reprogramming in mammalian nuclear transfer. Differentiation, 2003, 71(2): 91–113.
[9] Kurihara Y, Kawamura Y, Uchijima Y, Amamo T, Koba-yashi H, Asano T, Kurihara H. Maintenance of genomic methylation patterns during preimplantation development requires the somatic form of DNA methyltransferase 1. Dev Biol, 2008, 313(1): 335–346.
[10] Suetake I, Morimoto Y, Fuchikami T, Abe K, Tajima S. Stimulation effect of Dnmt3L on the DNA methylation ac-tivity of Dnmt3a2. J Biochem, 2006, 140(4): 553–559.
[11] Vaissiere T, Sawan C, Herceg Z. Epigenetic interplay be-tween histone modifications and DNA methylation in gene silencing. Mutat Res, 2008, 659(1–2): 40–48.
[12] Strahl BD, Allis CD. The language of covalent histone modifications. Nature, 2000, 403(6765): 41–45.
[13] Eilertsen KJ, Power RA, Harkins LL, Misica P. Targeting cellular memory to reprogram the epigenome, restore po-tential, and improve somatic cell nuclear transfer. Anim Reprod Sci, 2007, 98(1–2): 129–146.
[14] Lucio-Eterovic AK, Cortez MA, Valera ET, Motta FJ, Queiroz RG, Machado HR, Carlotti CG, Jr., Neder L, Scrideli CA, Tone LG. Differential expression of 12 his-tone deacetylase (HDAC) genes in astrocytomas and nor-mal brain tissue: class II and IV are hypoexpressed in glioblastomas. BMC Cancer, 2008, 8243.
[15] Wilson AJ, Byun DS, Popova N, Murray LB, L'Italien K, Sowa Y, Arango D, Velcich A, Augenlicht LH, Mariadason JM. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem, 2006, 281(19): 13548–13558.
[16] Witt O, Deubzer HE, Milde T, Oehme I. HDAC family: What are the cancer relevant targets? Cancer Lett, 2009, 277(1): 8–21.
[17] Klose RJ, Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol, 2007, 8(4): 307–318.
[18] Misri S, Pandita S, Kumar R, Pandita TK. Telomeres, his-tone code, and DNA damage response. Cytogenet Genome Res, 2008, 122(3–4): 297–307.
[19] Perez-Cadahia B, Drobic B, Davie JR. H3 phosphorylation: dual role in mitosis and interphase. Biochem Cell Biol, 2009, 87(5): 695–709.
[20] Shukla A, Chaurasia P, Bhaumik SR. Histone methylation and ubiquitination with their cross-talk and roles in gene expression and stability. Cell Mol Life Sci, 2009, 66(8): 1419–1433.
[21] Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev, 2004, 18(17): 2046–2059.
[22] Nathan D, Ingvarsdottir K, Sterner DE, Bylebyl GR, Dok- manovic M, Dorsey JA, Whelan KA, Krsmanovic M, Lane WS, Meluh PB, Johnson ES, Berger SL. Histone sumoyla- tion is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting |